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Edited by Thomas L. JamesAbstract We have compared the urea stability of the human
aromatic amino acid hydroxylases (AAAHs), key enzymes
involved in neurotransmitter biosynthesis and amino acid homeo-
stasis. Tyrosine-, tryptophan- and phenylalanine hydroxylase
(TH, TPH and PAH, respectively) were transiently activated at
low urea concentrations and rapidly inactivated in >3 M urea.
The denaturation of TH occurred through two cooperative
transitions, with denaturation midpoints of 1.41% 0.06 and
5.13% 0.05 M urea, respectively. Partially denatured human TH
(hTH) retained more of its secondary structure than human PAH
(hPAH), and was found to exist as tetramers, whereas hPAH
dissociated into dimers. Furthermore, the urea-induced aggrega-
tion of hPAH was 100-fold higher than for hTH. These results
suggest that the denatured state properties of the AAAHs
contribute signiﬁcantly to the stability of these enzymes and their
tolerance towards missense mutations.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Aggregation1. Introduction
The aromatic amino acid hydroxylases (AAAHs); phenyl-
alanine-, tyrosine- and tryptophan hydroxylase (PAH, TH and
TPH) have similar domain structure/organization, but diﬀer-
ent regulatory properties (for review see [1,2]). The AAAHs
have important roles in normal amino acid metabolism and
neurotransmitter biosynthesis, but have also been implicated
in various human disorders. For PAH, more than 400 diﬀerent
human mutations have been discovered, most of which are
associated with the severe metabolic disorder phenylketonuria
(http://data.mch.mcgill.ca/pahdb_new/). In contrast, very few
mutations have been found in the TH gene and no deﬁnite
mutations have been reported for TPH. Most of the known* Corresponding author. Fax: +47-555-86-360.
E-mail address: jan.haavik@biomed.uib.no (J. Haavik).
Abbreviations: AAAH, aromatic amino acid hydroxylase; TH, tyrosine
hydroxylase; hTH, human TH; PAH, phenylalanine hydroxylase;
TPH, tryptophan hydroxylase; CD, circular dichroism; LEM, linear
extrapolation method; SEC, size exclusion chromatography; DTT,
dithiothreitol
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doi:10.1016/j.febslet.2004.03.092PAH mutations cause a dramatic increase in the rate of en-
zyme aggregation and degradation [3], whereas at least some of
the TH mutations appear to be kinetic variants, with little
eﬀect on protein stability [4]. Thus, it can be speculated whe-
ther the AAAHs have fundamentally diﬀerent stabilities and
tolerances towards missense mutations, despite their overall
structural similarities.
Several investigations on TH stability have been performed,
including the eﬀects of enzyme phosphorylation [5–7]. How-
ever, only the thermal stability of the enzyme was examined
and conﬂicting results have been reported. Previously, we have
studied the solvent-induced denaturation of human PAH
(hPAH) [8], and here we apply intrinsic ﬂuorescence, circular
dichroism (CD), size exclusion chromatography (SEC), enzy-
matic activity and light scattering measurements to get com-
parable results for human TH1 (hTH1). The data presented
here indicate that although hPAH and hTH1 share many
structural and functional properties, they denature through
intermediates with diﬀerent physical properties. As puriﬁed
human TPH1 (hTPH1, peripheral type [9]) rapidly aggregates
even in the absence of denaturants [10], the investigations on
TPH stability were limited to activity studies.2. Materials and methods
2.1. Materials
Sodium chloride, EDTA and iron(II) sulfate were fromMerck. (6R)-
L-Erythro-5,6,7,8-tetrahydrobiopterin was purchased from Schircks
Laboratories (Switzerland). Dithiothreitol (DTT), catalase, HEPES
and thrombin were from Sigma, and urea from Fluka. 3,5-[3H]Tyro-
sine and [c-32P]ATP, Superdex 200 HR10/30 and the PC 3.2 column
were from Amersham Biosciences. All reagents were of analytical
grade.2.2. Expression and puriﬁcation of hydroxylases
Full-length hTH isoform 1 (hTH1; A1%280 ¼ 10:4 cm1 [11]) was ex-
pressed in E. coli and puriﬁed as described [12], whereas the puriﬁca-
tions of hPAH from E. coli and hTPH1 (peripheral type) from Pichia
pastoris were performed as described [10,13].
2.3. Urea denaturation and activity measurements
hTH1 and hTPH1 were preincubated with stoichiometric amounts
of FeSO4 and then exposed to diﬀerent concentrations of urea for 10
min, 25 C, before aliquotes were removed and immediately assayed
for remaining activity, as previously described [14]. The following
denaturing conditions were used: 0–7 M urea, 50 mM HEPES (pH
7.50), 200 mM NaCl and an enzyme concentration of 0.80 lM
subunit.blished by Elsevier B.V. All rights reserved.
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Fig. 1. Enzyme activity in the presence of urea. The loss of hTH1 (s),
hPAH () and hTPH1 (n) activity at diﬀerent urea concentrations was
measured after 10 min incubation at 25 C. Values are presented as
S.D. (n ¼ 3), or as an average of two diﬀerent experiments. The
values given are relative to 450, 740 and 10.7 nmolmin1 mg1 for
hTH1, hPAH and hTPH1, respectively. The data for hPAH are from
Kleppe et al. [8].
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TH was preincubated with stoichiometric amounts of FeSO4. De-
naturation was performed in darkness in 0–7.2 M urea, 50 mM Na–
HEPES (pH 7.5), 200 mM NaCl for 18 h, at 25 C using a protein
concentration of 44.8 lgml1 (0.80 lM subunit concentration), prior
to ﬂuorescence measurements. All data were obtained on a Perkin–
Elmer 50B ﬂuorimeter as previously described [8].
2.5. Size exclusion chromatography
The oligomeric forms of hTH1 and hPAH during urea denaturation
were analyzed by SEC. The samples were run on a Superdex 200 PC
3.2 column, connected to a Shimadzu HPLC system with UV absor-
bance detection at 280 nm. The column was calibrated and the chro-
matograms analyzed as described previously [8].
2.6. Light scattering measurements
The degree of protein aggregation was measured at 25 C as light
scattering, using a ﬂuorimeter (Perkin–Elmer 5OB). Excitation and
emission wavelengths were 295 and 300 nm, respectively, with slits of 3
and 4 nm. TH was incubated in the presence of stoichiometric amounts
of Fe(II)SO4 before addition to the denaturation assay and light
scattering measurements. Protein concentrations of 80 and 89.6
lgml1 were used for hPAH and hTH1, respectively (1.60 lM subunit
concentration).
2.7. Circular dichroism measurements
The CD spectra of TH at diﬀerent urea concentrations were deter-
mined at similar conditions as described above, except that 10 mM
KH2PO4 and 150 mM KF were used instead of HEPES and NaCl.
Control experiments were performed to verify that the ﬂuorescence
spectra and gel ﬁltration proﬁles were identical in phosphate and
HEPES buﬀers. The thermal stability of samples was measured at 222
nm, with 60 Ch1 increase in temperature.[urea] (M)
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Fig. 2. Urea denaturation of hTH1. After denaturing as described in
Section 2, the ﬂuorescence intensity at 345 nm was measured for each
sample. The data points are averages of two to three measurements,
the S.D. are given for three measurements, and both measurements are
shown for data points where only two exist (small open circles). The
best ﬁt to the data is shown in black.3. Results
3.1. Activation of AAAHs at low urea concentrations
After 10 min incubation at 25 C, the inactivation of hTH1
and hTPH1 was almost complete at 3.5–4 M urea (Fig. 1), and
the reduction of activity was very steep with almost complete
loss of activity going from 3.0 to 3.5 M urea. Interestingly, we
found a temporary activation of both TH and TPH at low
urea concentrations (6 1 M urea), very similar to hPAH [8].
Further experiments with incubation of TH at higher con-
centrations of urea for shorter time periods showed enzyme
activation up to 3 M urea, but that the rate of inactivation was
greatly increased. The maximal activation of the hydroxylases
by urea varied from 3% to 50% between diﬀerent enzyme
batches and decreased after repeated freezing and thawing,
indicating that it is dependent on the native conformation of
the enzyme.
3.2. Spectroscopic changes during denaturation of hTH1
The denaturation of hTH1 monitored by intrinsic protein
ﬂuorescence was very similar to what we have previously re-
ported for hPAH [8]. The tryptophan ﬂuorescence intensity of
hTH increased (76%) in 3.5 M urea, and then decreased again
(25%) at higher urea concentrations, corresponding to two
cooperative transitions (Fig. 2). We have previously observed a
2 nm red-shift of the emission maximum for hPAH during the
ﬁrst transition [8], but for hTH1 it remained unchanged
(342.5–343.0 nm). However, by complete denaturation the
emission maximum was red-shifted to 351 nm, as found for
bovine TH [11].
In order to investigate whether the two transitions reﬂected
major changes in the protein conformation, such as changes in
secondary structure or domain denaturation, we measured theCD spectra for hTH1 at diﬀerent concentrations of urea
(Fig. 3A). In the absence of denaturant, two characteristic
minima at 208 and 220 nm and a local maximum at 215 nm
were apparent. However, these were lost during the ﬁrst
transition, with a concomitant loss of CD signals between 210
and 245 nm. Typical spectra of random coil peptides were not
observed even at 7.5 M urea. For comparison, we also mea-
sured the CD spectra for hPAH at corresponding concentra-
tions of urea (Fig. 3B). The CD signal from hPAH was lower
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Fig. 3. Circular dichroism of denatured hTH1 and hPAH. The CD spectra of hTH1 (A) and the CD spectra of hPAH (B) are given at zero (—), 3.5
(–––) and 7.5 M urea (  ), 18 h incubation at 25 C. Insets: The thermal denaturation of hTH1 (A) and hPAH (B) at zero (1) and 3.5 M (2) urea
(18 h incubation at 25 C) is followed at 222 nm.
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subunit concentration was used for both). Similarly to TH,
native PAH displayed two local minima (208 and 220 nm) and
a local maximum (215.5 nm).
The ﬂuorescence data (Fig. 2) were used to calculate the
apparent free energy of denaturation for each transition by
using the linear extrapolation method (LEM, [15]) as previ-
ously described [8]. The thermodynamic values calculated
show considerably lower apparent free energy of denaturation
for hTH1 (11.13 0.56 and 29.1 2.1 kJmol1, ﬁrst transition
and last transition, respectively) than previously estimated
values for hPAH (21 2 and 57 5 kJmol1, ﬁrst transition
and last transition, respectively [8]). However, only for the last
transition did the diﬀerent midpoints of denaturation, i.e., 5.1
and 5.7 M, reﬂect the diﬀerent free energy values. The corre-
sponding denaturation index values for hTH1 for each tran-
sition were estimated to be )7.89 0.42 and )5.67 0.41
kJ litermol2. All values are given S.E. obtained from the
nonlinear regression analysis.
Denaturation of proteins by temperature and urea occurs by
diﬀerent mechanisms, and the results are not always compa-
rable. This is also true for the AAAHs studied here. Thus, the
CD spectra of hTH and hPAH after complete thermal dena-
turation were stronger than after denaturation at 25 C in 7.5
M urea, suggesting that urea denaturation gives more unfolded
states. These observations may be relevant when comparing
results obtained by thermal and solvent denaturation of the
AAAHs.
3.3. The tetrameric structure of hTH1 is more stable than for
hPAH
It is well documented that under physiological conditions
TH exists as a tetramer, whereas native PAH exists in an
equilibrium between tetramers and dimers [8]. Our SEC data
were in accordance with this, showing a single molecular
species of native hTH1 with a Stokes radius of 59 A. The
eﬀect of denaturation on the oligomeric structure of theAAAHs was studied by analyzing the urea denatured pro-
teins by SEC. This analysis showed diﬀerences between
hPAH and hTH1. For hPAH, the chromatograms were re-
solved into denatured and native tetramers and dimers, where
only the denatured dimer form was detected after the ﬁrst
transition (2 M urea), as reported previously [8,16]. However,
in 2 M urea hTH1 still existed as a (denatured) tetramer with
an increased Stokes radius (65 A) compared to the native
enzyme. Further increase in the urea concentration above 4 M
resulted in formation of unfolded monomeric forms for both
hPAH and hTH1, with apparent molecular dimensions ex-
ceeding even their native tetrameric forms (hTH1 Stokes ra-
dius 69 A in 8 M urea). Further addition of denaturant
increased the apparent size of the denatured species of both
hTH1 and hPAH, as expected for a gradual unfolding to
random coils.
3.4. Diﬀerent aggregation of partially denatured hTH1 and
hPAH
During denaturation hydrophobic residues may be exposed
to the solvent and cause protein aggregation, in spite of the
generally solvating properties of urea. We have previously
reported such behavior for hPAH and for comparison we in-
vestigated the aggregating properties of hTH1 during urea-
induced denaturation. We found only modest changes in the
aggregation of hTH1 at diﬀerent urea concentrations (Fig. 4B),
and the increase in light scattering was almost linear with time,
as opposed to the typical sigmoid curves observed for hPAH
(Fig. 4A and [8]). The maximal rate of aggregation for hTH1
was at 3 M urea, compared to about 1.5 M for hPAH (Fig. 4A
and [8]). In order to get quantitative estimates of the rate of
aggregation, we applied linear regression analysis to the light
scattering curves in the steep sigmoid area and to all data
points for linear light scattering curves. Compared to hTH1,
hPAH displayed a strong tendency to aggregate, with the
maximal empirical rate of aggregation being 100-fold higher
than that of TH (Fig. 4C).
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Fig. 4. Protein aggregation. Light scattering measurements were used
to monitor the aggregation of hPAH (A) and hTH1 (B) at diﬀerent
concentrations of urea as described in Section 2. For (A), the increase
in light scattering is shown at zero (s), 1 M (), 2 M (n), 3 M (r) and
6 M () urea. The regression line in the steepest area of the curves is
used as an empirical estimate of the rate of aggregation. Similarly, for
hTH1 (B) the light scattering is shown at zero (s), 1 M (), 2 M (n), 3
M (,) and 5 M (s) urea. (C) The slope of each regression curve for
hPAH (s) and hTH1 () is used to visualize the diﬀerence in rate/
degree of aggregation. The data for hTH1 displayed at two diﬀerent
scales, the left axis corresponding to the scale for the hPAH data.
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In this study we compare the solvent stability of the struc-
turally related AAAHs, revealing both similarities and im-
portant diﬀerences. The denaturation of such multi-domain
oligomeric proteins is expected to be a complicated process,where the possible denaturation pathways depend on the
intrinsic stabilities of the domains and domain–domain in-
teractions both within each subunit and between diﬀerent
subunits. Together with previous studies on the denaturation
of these enzymes, we show that these properties are impor-
tant determinants of their stability and pathway of denatur-
ation.
The observed activation at low denaturing conditions is
probably related to common domain organization of the
AAAHs, and several agents which activate the AAAHs exert
their eﬀects through the N-terminal regulatory domain
[17–21]. The structure and stability of these intermediately
denatured proteins are not presently known, however, it seems
probable that some structural changes involving the N-
terminal regulatory domain are occurring even at low urea
concentrations, and that the activation seems to reﬂect a
transiently populated intermediate. Experiments on the N-
terminal truncated enzymes support this, and several studies
by thermal denaturation of hPAH have shown that dena-
turation of the N-terminal domain occurs prior to other
major structural changes [22]. In addition, urea denaturation
studies on tryptophan to phenylalanine hPAH mutants sug-
gest that major structural changes occur in the N-terminal of
the enzyme [8].
However, for hPAH, we have found that the ﬁrst transi-
tion not only involves the unfolding of the N-terminal do-
main, but also dissociation of the tetramer to a dimeric
N-terminal denatured hPAH. Here we report that hTH1
keeps its tetrameric structure throughout the ﬁrst transition,
suggesting that the C-terminal oligomerization domain of
hTH is more stable than for hPAH. An alternative expla-
nation would be that some of the tetrameric hPAH disap-
peared by aggregation, but the CD data support more
residual secondary structure of the partially denatured hTH
than of hPAH. In fact, these data suggest that for both en-
zymes more secondary structure is lost during the ﬁrst de-
naturation transition than can be attributed to the N-terminal
domain alone. Thus, it seems that lower energy is needed to
partially denature hTH1, but the state reached contains more
residual structure as compared to hPAH.
For several decades the LEM method of Greene and Pace
has been applied to get estimates of the thermodynamic sta-
bilities of proteins. However, even in the recent literature we
ﬁnd no clear consensus on how this method should be applied
to oligomeric proteins. For that reason, we have used the
simplest approach where the oligomeric structure is not con-
sidered, which means that the values obtained depend on the
conditions chosen. Thus, we used equal subunit concentrations
for hTH1 and hPAH to get comparable results. The lower
apparent stability of hTH1 than for hPAH is in agreement
with previous ﬁndings on the thermal stabilities of TH and
PAH [5,22,23]. However, according to the CD data (inset of
Fig. 3A and B), thermal and urea denaturation is diﬀerent for
TH and PAH.
One of the most remarkable diﬀerences between hTH1 and
hPAH was the distinct pattern of aggregation of these pro-
teins observed during denaturation, which reﬂects diﬀerences
in structures and properties of their denaturing intermediates.
Due to the similar denaturation midpoints for hPAH and
hTH1, this property is directly comparable for the two en-
zymes. Interestingly, the lower extent of aggregation observed
for TH was similar to that of PAH in the presence of satu-
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meric proteins suggest that the N-terminal domain is im-
portant for the aggregation of PAH. In particular, exchange
of the N-terminal domain of rat TH with that of rat PAH
gave lower puriﬁcation yield and higher amount of inclusion
bodies than the wild type TH [24]. Furthermore, the N-ter-
minal of TH was found to increase the solubility of PAH
compared to the wild type [24]. Puriﬁcation of the hPAH N-
terminal domain has also proven to be diﬃcult due to protein
aggregation [25].
The process of protein denaturation depends on the sta-
bility of the native state relative to the transition and dena-
tured states. Whereas the free energy of strongly unfolded
proteins would be expected to be minimally aﬀected by mu-
tations, such simpliﬁcation will not apply to more compact
denatured states [26]. Hence, we expect that the partially de-
natured states of the AAAHs will play an important role in
the stability of these enzymes, given the signiﬁcant residual
structure found for these states. Furthermore, since the par-
tially denatured states are diﬀerent between the hydroxylases,
their response to homologous missense mutations may be less
predictable than expected from studies on their native struc-
tures alone. It is tempting to speculate that the strong ten-
dency of PAH to aggregate may explain the existence of
numerous diﬀerent mutations (>400) associated with phen-
ylketonuria, as opposed to the paucity of known mutations in
TH. The strong tendency of puriﬁed TPH to precipitate is
puzzling and has prevented us from performing a complete
comparison of all members of the AAAH family. Further-
more, the aggregating properties of the latter enzyme have
raised the question whether TPH and the other AAAHs are
stabilized in vivo by additional molecular interactions [10].
With such a low stability as reported here for hTH1 and
hTPH1, one might speculate if it has a physiological signiﬁ-
cance in the regulation of catecholamine and serotonin bio-
synthesis, e.g., by placing more control of the biosynthesis to
protein turnover.
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